ARTICLE | Clinical News
Viramune nevirapine regulatory update
September 20, 2010 7:00 AM UTC
The EC approved an updated label for Boehringer's Viramune nevirapine to treat HIV-1 infection to allow patients with an undetectable viral load to use the drug regardless of CD4 count. The non-nucleo...